author-photo

Aarti Sonia Bhardwaj

Icahn School of Medicine at Mount Sinai

23

Papers

68

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Implementing clinical decision support for oncology advanced care planning: A systems engineering framework to optimize the usability and utility of a machine learning predictive model in clinical practice.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Swabs by emergency responders (SWABBER): Enhancing care beyond the cancer center during the COVID-19 pandemic.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Redesigning care coordination from the patient’s perspective.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
EHR innovations to optimize cancer care delivery in New York City during the COVID-19 pandemic.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Results of a phase Ib study investigating durvalumab in combination with eribulin in patients with metastatic HER2-negative breast cancer and recurrent ovarian cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Tag you’re it! Development of a clinical decision support tool to identify NCCN regimens without a costly pathways program.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer

2019 Science Advances
Show All
- Source
- Cite
- Save
Citations (42)
Improving the chemotherapy consent: From paper to tablet.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT1-03-08: A multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab and pertuzumab in HR-positive, Her2-positive metastatic breast cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A phase Ib study evaluating the safety and tolerability of durvalumab in combination with eribulin in patients with HER2-negative metastatic breast cancer and recurrent ovarian cancer.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)